Vanguard Group Inc Merrimack Pharmaceuticals Inc Transaction History

Vanguard Group Inc

$5.46 Trillion
Q3 2024

Shares

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q1 2024 May 10, 2024	BUY	$13.06 - $15.0 $155,322 - $178,395	11,893 Added 1.95%	620,847 $9.17 Million
Q4 2023 Feb 14, 2024	BUY	$12.02 - $13.41 $103,492 - $115,460	8,610 Added 1.43%	608,954 $8.17 Million
Q3 2023 Nov 14, 2023	BUY	$11.6 - $12.52 $505,133 - $545,195	43,546 Added 7.82%	600,344 $7.4 Million
Q2 2023 Aug 14, 2023	BUY	$12.02 - $13.07 $1.18 Million - $1.28 Million	98,277 Added 21.43%	556,798 $6.85 Million
Q1 2023 May 15, 2023	SELL	$11.35 - $12.32 $1.47 Million - $1.6 Million	-129,500 Reduced 22.02%	458,521 $5.64 Million
Q4 2022 Feb 10, 2023	SELL	$3.68 - $12.51 $72,801 - $247,485	-19,783 Reduced 3.25%	588,021 $6.74 Million
Q3 2022 Nov 14, 2022	SELL	$3.7 - $6.06 $1,480 - $2,424	-400 Reduced 0.07%	607,804 $2.28 Million
Q1 2022 May 13, 2022	SELL	$3.75 - $6.82 $32,415 - $58,952	-8,644 Reduced 1.4%	608,204 $3.85 Million
Q4 2021 Feb 14, 2022	SELL	$3.75 - $5.1 $6,603 - $8,981	-1,761 Reduced 0.28%	616,848 $2.41 Million
Q2 2021 Aug 13, 2021	BUY	$6.04 - $7.77 $3.74 Million - $4.81 Million	618,609 New	618,609 $3.95 Million

Others Institutions Holding MACK

# of Institutions

2

Shares Held

349

Call Options Held

0

Put Options Held

0

About MERRIMACK PHARMACEUTICALS INC

Ticker MACK
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 13,410,200
Market Cap $203M
Description
Merrimack Pharmaceuticals, Inc. operates as a biopharmaceutical company. The company was incorporated in 1993 and is headquartered in Cambridge, Massachusetts.

More about MACK

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Vanguard Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Vanguard Group Inc with notifications on news.